Rational antibody design for undruggable targets using kinetically controlled biomolecular probes - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/33863724/

1 Oblique Therapeutics AB, SE-41346 Gothenburg, Sweden. 2 Department of Physiology and Pharmacology, Karolinska Institutet, SE-171 77 Stockholm, Sweden. 3 Nanoxis Consulting AB, SE-40016 Gothenburg, Sweden. 4 Integrative Research Laboratories, SE-41346, Gothenburg, Sweden. 5 Fluicell AB, SE-431 37 Mölndal, Sweden. 6 Department of Chemistry and Molecular Biology, University of Gothenburg, SE-405 30 Gothenburg, Sweden.